Global Preclinical Tomography System Market Size By Type (CT, PETAndSPECT), By Application (Biopharmaceuticals, Research Institute), By Region, And Segment Forecasts, 2023 to 2032

The Global Preclinical Tomography System Market was valued at USD 685 million in 2023 and is projected to reach USD 1.1 billion by 2031, growing at a CAGR of 6.4% during the forecast period from 2023 to 2031. The growing emphasis on early-stage drug development, increasing investments in preclinical research, and technological advancements in imaging systems are key drivers of market growth. These systems play a pivotal role in non-invasive, high-resolution visualization of biological processes in small animals, aiding pharmaceutical and biotechnology companies in streamlining drug discovery and disease research.

Drivers

1. Rising Focus on Early Drug Development:

Pharmaceutical companies are increasingly investing in advanced imaging technologies to improve the efficiency and reliability of preclinical trials, which significantly fuels the demand for preclinical tomography systems.

2. Technological Advancements in Imaging Modalities:

The market is experiencing a surge in innovations, including hybrid systems combining PET, SPECT, and CT, which enhance image resolution, throughput, and diagnostic capabilities.

3. Growing Use in Oncology and Neurology Research:

Tomography systems are extensively used in cancer and brain disease research, where high-resolution functional and anatomical imaging is essential for preclinical validation and translational research.

Restraints

1. High Equipment and Maintenance Costs:

The high cost of acquisition and upkeep of preclinical tomography systems remains a significant barrier for small research institutions and universities.

2. Regulatory and Ethical Challenges in Animal Testing:

Stringent regulations and growing ethical concerns surrounding the use of animal models in research may impede market growth in certain regions.

Opportunity

1. Integration with Artificial Intelligence:

Incorporating AI and machine learning algorithms with tomography systems offers immense potential for automated image analysis and predictive modeling, opening new avenues for innovation.

2. Expansion in Emerging Markets:

Rising healthcare R&D expenditure and improving infrastructure in countries across Asia-Pacific and Latin America present untapped opportunities for market expansion.

Market by System Type Insights

The PET/CT segment accounted for the largest market share in 2023 due to its combined anatomical and functional imaging capabilities, making it the preferred choice in oncology and cardiology research. The SPECT/CT segment is also growing steadily, driven by its cost-effectiveness and versatility in multiple preclinical applications.

Market by End-use Insights

Pharmaceutical and Biotechnology Companies dominated the end-use segment in 2023, holding more than 45% of the market share. These systems are integral to drug screening, efficacy testing, and toxicity assessment. Academic and research institutions are also significant users, supported by public and private research funding.

Market by Regional Insights

North America led the global preclinical tomography system market in 2023, supported by strong R&D infrastructure, high healthcare investment, and the presence of major manufacturers. The Asia-Pacific region is projected to experience the fastest growth, propelled by increasing investments in biomedical research and rising demand for advanced imaging technologies.

Competitive Scenario

Leading players in the market include Bruker Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., MILabs B.V., Mediso Ltd., and MR Solutions Ltd. These companies focus on strategic partnerships, R&D investments, and product innovation to strengthen their market presence.

Scope of Work – Global Preclinical Tomography System Market

Report Metric Details

Market Size (2023) USD 685 million

Projected Market Size (2031) USD 1.1 billion

CAGR (2023–2031) 6.4%

Market Segments System Type (PET/CT, SPECT/CT, Optical), End-use

Growth Drivers Rising demand for early drug development, technological innovations

Opportunities AI integration, market expansion in Asia-Pacific

Key Market Developments

2023: Bruker Corporation introduced an AI-powered image analysis module integrated into its PET/CT platform to enhance efficiency in preclinical research.

2024: Mediso Ltd. launched a next-generation multimodal imaging system tailored for oncology and neurology research.

2025: FUJIFILM VisualSonics entered a strategic partnership with a leading biotech firm to co-develop advanced imaging biomarkers for cardiovascular diseases.

FAQs

What is the current market size of the Global Preclinical Tomography System Market?

The market was valued at USD 685 million in 2023.

What is the major growth driver of the Global Preclinical Tomography System Market?

The primary growth driver is the increasing focus on early-stage drug development and preclinical research.

Which is the largest region during the forecast period in the Global Preclinical Tomography System Market?

North America is expected to remain the largest region throughout the forecast period.

Which segment accounted for the largest market share in the Global Preclinical Tomography System Market?

The PET/CT system type segment held the largest share in 2023.

Who are the key market players in the Global Preclinical Tomography System Market?

Major players include Bruker Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., MILabs B.V., Mediso Ltd., and MR Solutions Ltd.